Readystate Asset Management’s Gilead Sciences GILD Stock Holding History

Readystate Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$655K	Buy	+4,700	New	+$658K	0.03%	547
2025 Q2	–	Sell	-26,900	Closed	-$3.01M	–	728
2025 Q1	$3.01M	Buy	26,900 +4,700	+21%	+$485K	0.1%	237
2024 Q4	$2.05M	Sell	22,200 -44,200	-67%	-$3.98M	0.06%	303
2024 Q3	$5.57M	Buy	+66,400	New	+$5.07M	0.1%	280
2024 Q2	–	Sell	-20,600	Closed	-$1.51M	–	875
2024 Q1	$1.51M	Sell	20,600 -22,100	-52%	-$1.7M	0.02%	626
2023 Q4	$3.46M	Buy	42,700 +39,700	+1,323%	+$3.09M	0.12%	181
2023 Q3	$225K	Hold	3,000	–	–	0.01%	483
2023 Q2	$231K	Sell	3,000 -1,000	-25%	-$79.8K	0.02%	260
2023 Q1	$332K	Buy	+4,000	New	+$331K	0.03%	186

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Readystate Asset Management's GILD Position: Q2 2025 in Review

Readystate Asset Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 5,797 shares — an estimated $650K sold.

Readystate Asset Management first reported a position in GILD in Q4 2023 and held it in 3 quarters. The position peaked at $650K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Readystate Asset Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
Readystate Asset Management sold 5,797 Gilead Sciences shares in Q2 2025, an estimated $650K.
Readystate Asset Management first reported a position in Gilead Sciences in Q4 2023 and held it in 3 quarters.
Readystate Asset Management's Gilead Sciences position peaked at $650K in Q1 2025.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.